Melissa Tosca's most recent trade in Kiora Pharmaceuticals Inc was a trade of 911 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharma Inc | Melissa Tosca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.66 per share. | 01 Jul 2026 | 911 | 26,064 (0%) | 0% | 2.7 | 2,423 | Common Stock |
| Kiora Pharma Inc | Melissa Tosca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.95 per share. | 01 Apr 2026 | 929 | 26,975 (0%) | 0% | 2.0 | 1,812 | Common Stock |
| Kiora Pharma Inc | Melissa Tosca | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 13,067 | 13,067 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Melissa Tosca | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 6,533 | 27,904 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Melissa Tosca | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 15,543 | 15,543 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Melissa Tosca | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 7,772 | 21,371 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Melissa Tosca | CFO | Purchase of securities on an exchange or from another person at price $ 3.21 per share. | 14 Aug 2024 | 2,000 | 13,599 (0%) | 0% | 3.2 | 6,420 | Common Stock |
| Kiora Pharma Inc | Melissa Tosca | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 15,239 | 15,239 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Melissa Tosca | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 7,620 | 11,599 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Melissa Tosca | EVP Finance | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 14 Jun 2024 | 100 | 3,979 (0%) | 0% | 5.3 | 525 | Common Stock |
| Kiora Pharma Inc | Melissa Tosca | EVP Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 2,400 | 7,400 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Melissa Tosca | EVP Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 1,600 | 1,600 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Melissa Tosca | EVP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Melissa Tosca | EVP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 2,500 | 2,500 (0%) | 0% | 0 | Common Stock |